ACBP: a poor-prognosis biomarker in sepsis and a target for disease mitigation II
RNA-seq (gene expression) · mouse · 40 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 40 samples: 8 conditions, mostly with about 6 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigationSignal transduction and targeted therapy · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE304861_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1303081 and SRA study SRP607361. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 40 samples.
How we read this: 8 replicated groups read from 40 sample titles; they account for 40 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9158504 Sham+PBS/IgG_1 Sham+PBS/IgG
- GSM9158505 Sham+PBS/IgG_2 Sham+PBS/IgG
- GSM9158506 Sham+PBS/IgG_3 Sham+PBS/IgG
- GSM9158507 Sham+PBS/IgG_4 Sham+PBS/IgG
- GSM9158508 Sham+DEX/IgG_1 Sham+DEX/IgG
- GSM9158509 Sham+DEX/IgG_2 Sham+DEX/IgG
- GSM9158510 Sham+DEX/IgG_3 Sham+DEX/IgG
- GSM9158511 Sham+DEX/IgG_4 Sham+DEX/IgG
- GSM9158512 Sham+PBS/aDBI_1 Sham+PBS/aDBI
- GSM9158513 Sham+PBS/aDBI_2 Sham+PBS/aDBI
- GSM9158514 Sham+PBS/aDBI_3 Sham+PBS/aDBI
- GSM9158515 Sham+PBS/aDBI_4 Sham+PBS/aDBI
- GSM9158516 Sham+DEX/aDBI_1 Sham+DEX/aDBI
- GSM9158517 Sham+DEX/aDBI_2 Sham+DEX/aDBI
- GSM9158518 Sham+DEX/aDBI_3 Sham+DEX/aDBI
- GSM9158519 Sham+DEX/aDBI_4 Sham+DEX/aDBI
- GSM9158520 CLP+PBS/IgG_1 CLP+PBS/IgG
- GSM9158521 CLP+PBS/IgG_2 CLP+PBS/IgG
- GSM9158522 CLP+PBS/IgG_3 CLP+PBS/IgG
- GSM9158523 CLP+PBS/IgG_4 CLP+PBS/IgG
- GSM9158524 CLP+PBS/IgG_5 CLP+PBS/IgG
- GSM9158525 CLP+PBS/IgG_6 CLP+PBS/IgG
- GSM9158526 CLP+DEX/IgG_1 CLP+DEX/IgG
- GSM9158527 CLP+DEX/IgG_2 CLP+DEX/IgG
- GSM9158528 CLP+DEX/IgG_3 CLP+DEX/IgG
- GSM9158529 CLP+DEX/IgG_4 CLP+DEX/IgG
- GSM9158530 CLP+DEX/IgG_5 CLP+DEX/IgG
- GSM9158531 CLP+DEX/IgG_6 CLP+DEX/IgG
- GSM9158532 CLP+PBS/aDBI_1 CLP+PBS/aDBI
- GSM9158533 CLP+PBS/aDBI_2 CLP+PBS/aDBI
- GSM9158534 CLP+PBS/aDBI_3 CLP+PBS/aDBI
- GSM9158535 CLP+PBS/aDBI_4 CLP+PBS/aDBI
- GSM9158536 CLP+PBS/aDBI_5 CLP+PBS/aDBI
- GSM9158537 CLP+PBS/aDBI_6 CLP+PBS/aDBI
- GSM9158538 CLP+DEX/aDBI_1 CLP+DEX/aDBI
- GSM9158539 CLP+DEX/aDBI_2 CLP+DEX/aDBI
- GSM9158540 CLP+DEX/aDBI_3 CLP+DEX/aDBI
- GSM9158541 CLP+DEX/aDBI_4 CLP+DEX/aDBI
- GSM9158542 CLP+DEX/aDBI_5 CLP+DEX/aDBI
- GSM9158543 CLP+DEX/aDBI_6 CLP+DEX/aDBI
- GSE313149 ACBP: a poor-prognosis biomarker in sepsis and a target for disease mitigation [Lung] 50 samples shares acbp, poor-prognosis, mitigation, biomarker, sepsis, target
- GSE304860 ACBP: a poor-prognosis biomarker in sepsis and a target for disease mitigation 28 samples shares acbp, poor-prognosis, mitigation, biomarker, sepsis, target
- GSE298176 CTHRC1 is a new therapeutic target and serum diagnostic biomarker for aortic dissection 54 samples shares biomarker, target
- GSE297831 Imidazole propionate is an early biomarker and therapeutic target for atherosclerosis [bulk RNA-seq] 27 samples shares biomarker, target
- GSE337190 CAR-NKT cells induce low cytokine release syndrome by targeting hyperinflammatory macrophages with mitigation from GM-SCF inhibition. 24 samples shares mitigation, target
- GSE297519 CTHRC1 is a new therapeutic target and serum diagnostic biomarker for aortic dissection [MOVAS_rhCTHRC1_RNAseq] 24 samples shares biomarker, target
- GSE297518 CTHRC1 is a new therapeutic target and serum diagnostic biomarker for aortic dissection [Cthrc1_wt_ko_RNAseq] 24 samples shares biomarker, target
- GSE297887 Per2 mediates neuroinflammation-driven depression after spinal cord injury and serves as a biomarker-target 7 samples shares biomarker, target
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.